Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial.

Karyn A. Goodman,Fang Shu Ou,Nathan Hall,Tanios Bekaii-Saab,Briant Fruth,Erin Twohy,Michael O. Meyers,Daniel J. Boffa,Kisha Mitchell,Wendy L. Frankel,Donna Niedzwiecki,Anne M. Noonan,Yelena Y. Janjigian,Paul J. Thurmes,Alan P. Venook,Jeffrey A. Meyerhardt,Eileen M. OReilly,David H. Ilson

Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial.

2021

Karyn A. Goodman
Fang Shu Ou
Nathan Hall
Tanios Bekaii-Saab
Briant Fruth
Erin Twohy
Michael O. Meyers
Daniel J. Boffa
Kisha Mitchell
Wendy L. Frankel
Donna Niedzwiecki
Anne M. Noonan
Yelena Y. Janjigian
Paul J. Thurmes
Alan P. Venook
Jeffrey A. Meyerhardt
Eileen M. OReilly
David H. Ilson

PURPOSETo evaluate the use of early assessment of chemotherapy responsiveness by positron emission tomography (PET) imaging to tailor therapy in patients with esophageal and esophagogastric junctio...

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations